What Is the Wegovy Pill? Effectiveness, Dosing & How It Compares to Injections

Key Takeaways

The Wegovy pill is a once-daily oral semaglutide tablet formulated specifically for chronic weight management (BMI ≥30, or ≥27 with a weight-related comorbidity).
In the 64-week OASIS-4 trial, adults taking the 25mg Wegovy tablet lost an average of 14%–17% of starting weight — bioequivalent in clinical outcomes to the 2.4mg weekly Wegovy injection.
Around 90% of trial participants lost ≥5% of body weight, ~70% lost ≥10%, and ~50% lost ≥15%.
You must never take the Wegovy pill alongside Wegovy, Ozempic, or Mounjaro injections, though clinician-guided switching between injection and tablet is straightforward.

For years, patients seeking high-efficacy GLP-1 weight management had only injectable pen options. The Wegovy pill delivers semaglutide — backed by global clinical experience across more than 22 million patients — in a once-daily tablet that requires no needles and no refrigerator storage.

How Effective Is the Wegovy Pill? (OASIS-4 Trial Results)

At its 25mg daily maintenance strength, oral Wegovy achieves systemic semaglutide exposure matching the 2.4mg once-weekly Wegovy injection. Across 64 weeks in the Phase 3 OASIS-4 study alongside lifestyle support:

14% to 17% mean reduction in baseline body weight (~15% overall average)
~90% of participants lost ≥5% of starting weight (the clinical threshold that measurably improves blood pressure, triglycerides, and glycemic control)
~70% lost ≥10% of body weight
~50% lost ≥15%, and ~25% lost 20% or more

Wegovy Pill vs. Wegovy Weekly Injection

Feature	Wegovy Pill (1.5mg -> 25mg)	Wegovy Injection (0.25mg -> 2.4mg / 7.2mg)
Dosing frequency	Once every morning	Once per week
Food & drink rules	Empty stomach, ≤120mL water, wait 30 min	Any time of day, with or without meals
Storage & travel	Room temperature (no fridge needed)	Refrigerate unopened pens (2°C–8°C)
Average 64–68 wk weight loss	~14%–17% (at 25mg)	~15%–17% (at 2.4mg); up to 19%–21% (at 7.2mg)
Best suited for	Needle-averse patients, frequent travelers, daily pill habit	Patients who prefer coffee right on waking or weekly simplicity

Can You Switch Between Injections and Tablets?

Yes — under clinician guidance, patients stable on the 2.4mg weekly Wegovy injection can transition directly to the 25mg daily tablet starting 7 days after their final injection (see our injection-to-pill switching guide). Patients on lower pen strengths step onto the matching oral titration tier (1.5mg -> 4mg -> 9mg -> 25mg). Never combine oral and injectable GLP-1 medications simultaneously.

References

Schweitzer K. What to Know About the Wegovy Pill for Obesity. JAMA. 2026.
Wharton S, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. N Engl J Med. 2025;393(11):1077–1087.

Medical Editorial Review: Reviewed by the Amble Clinical Editorial Team. This article is for educational purposes only and does not replace an individualized consultation with a licensed healthcare professional.